New indication concerns treatment of patients with resectable locally advanced head and neck squamous cell carcinoma
Αρχική World News EMA Recommends Extending Indications for Pembrolizumab and Adopted a New Pharmaceutical Form...
New indication concerns treatment of patients with resectable locally advanced head and neck squamous cell carcinoma